Omnimmune Holdings (Omnimmune Holdings) Net Income From Continuing Operations : $-1.79 Mil (TTM As of Sep. 2010)

View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Omnimmune Holdings's net income from continuing operations for the three months ended in Sep. 2010 was $-0.30 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2010 was $-1.79 Mil.

Omnimmune Holdings Net Income From Continuing Operations Historical Data

The historical data trend for Omnimmune Holdings's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Net Income From Continuing Operations Chart

Omnimmune Holdings Annual Data

Trend

May07

May08

Dec09

Net Income From Continuing Operations

-0.01

-0.05

-1.76

Omnimmune Holdings Quarterly Data
	May07	Aug07	Nov07	Feb08	May08	Aug08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10
Net Income From Continuing Operations	Get a 7-Day Free Trial									-0.46	-0.46	-1.00	-0.03	-0.30

Omnimmune Holdings Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.79 Mil.

Omnimmune Holdings (Omnimmune Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027

Website

Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines